We have determined the effect of applying
Mannose-6-Phosphate (M6P), a
scar reducing agent, to a site of sciatic nerve repair. In anaesthetised C57-Black-6 mice, the left sciatic nerve was sectioned and repaired using 4 epineurial
sutures. Either 100 μl of 600 mM
Mannose-6-Phosphate (29 animals), or 100 μl of
phosphate buffered saline as a placebo control (29 animals), was injected into and around the nerve repair site. A further group acted as
sham-operated controls. After 6 or 12 weeks of recovery the extent of regeneration was assessed electrophysiologically and the percentage area of
collagen staining at the repair site was analysed using
picrosirius red and image analysis. Gait analysis was undertaken pre-operatively and at 1, 3, 6, 9 and 12 weeks postoperatively, to assess functional recovery. At 6 weeks the compound action potentials recorded from the regenerated nerves in the M6P group were significantly larger than in the placebo controls (P=0.015), and the conduction velocities were significantly faster (P=0.005), but there were no significant differences between these groups at 12 weeks. Gait analysis suggested better early functional recovery in the M6P group. In both repair groups there was a significant reduction in
collagen staining between 6 and 12 weeks, suggestive of
scar remodelling. We conclude that the normal
scar remodelling process
aids long term recovery in repaired nerves. Administration of 600 mM M6P to the nerve repair site enhances nerve regeneration and functional recovery in the early stages, and may lead to improved outcomes.